Commonly found variations/mutations in the HBsAg of Hepatitis B virus in the context of effective immunization programs: Questionable clinical and public health significance

Journal of Virology

Volumn 88, Issue 11, 2014, Pages 6532-

  Locarnini, Stephen ^a   Shouval, Daniel ^b  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; NATURAL SELECTION; PRIORITY JOURNAL; VACCINATION; VIREMIA; VIRUS MUTATION;

FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MUTATION;

EID: 84899886061     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00234-14     Document Type: Letter

References (8)

1. Bian T, Yan H, Shen L, Wang F, Zhang S, Cao Y, Zhang Y, Bi S. 2013. Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China. J. Virol. 87:12196-12206. http://dx. doi. org/10. 1128/JVI. 02127-13.
2. Bian T, Yan H, Shen L, Wang F, Zhang S, Cao Y, Zhang S, Zhang Y, Bi S. 2013. Universal hepatitis B vaccination in China boosts breakthrough mutant viruses. Microbe 8:393-394.
3. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329. http://dx. doi. org/10. 1016/0140-6736(90)91874-A.
4. Kamili S, Sozzi V, Thompson G, Campbell K, Walker CM, Locarnini S, Krawczynski K. 2009. Efficacy of hepatitis B vaccine against antiviral drugresistant hepatitis B virus mutants in the chimpanzee model. Hepatology 49:1483-1491. http://dx. doi. org/10. 1002/hep. 22796.
5. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, Gerken G. 1998. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27:254-263. http://dx. doi. org/10. 1002/hep. 510270138.
6. Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF. 2004. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine 22:2791-2799. http://dx. doi. org/10. 1016/j. vaccine. 2004. 01. 046.
7. Shouval D, Locarnini S. 2012. Increased prevalence of HBV envelope mutants in Taiwan: an emerging public health risk or a false alarm? Gastroenterology 143:290-293. http://dx. doi. org/10. 1053/j. gastro. 2012. 06. 026.
8. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B andDvirus. eLife 1:e00049. http://dx. doi. org/10. 7554/eLife. 00049.